Mount Sinai Unveils New Sleep Research
Researchers will present studies at SLEEP 2024, covering CPAP withdrawal effects, hypoxic burden in OSA treatment, and new diagnostic tools.
Stay updated with breaking news from Andreww Varga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers will present studies at SLEEP 2024, covering CPAP withdrawal effects, hypoxic burden in OSA treatment, and new diagnostic tools.
Mount Sinai researchers claim to have discovered a novel therapy for rapid eye movement (REM) sleep behaviour disorder
REM sleep behaviour disorder is a condition, mostly affecting adults aged over 50, in which one often unknowingly physically acts out their dreams with vocal sounds or sudden, violent arm and leg movements during slumber, leading to significant injury to themselves or bed partners.
Experts say medication commonly used to treat insomnia may also be a therapeutic option for the condition known as REM sleep behavior disorder.
Researchers have found sleep medications commonly used to treat insomnia, or difficulty falling and remaining asleep, to significantly reduce rapid eye movement (REM) sleep behaviour disorder. The study findings suggested that these medications,